5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.53▲ | 2.52▲ | 2.52▲ | 2.40▲ | 2.41▲ |
MA10 | 2.52▲ | 2.51▲ | 2.47▲ | 2.32▲ | 2.35▲ |
MA20 | 2.52▲ | 2.44▲ | 2.43▲ | 2.37▲ | 2.17▲ |
MA50 | 2.46▲ | 2.40▲ | 2.33▲ | 2.41▲ | 1.87▲ |
MA100 | 2.43▲ | 2.31▲ | 2.32▲ | 2.11▲ | 2.26▲ |
MA200 | 2.33▲ | 2.35▲ | 2.31▲ | 1.81▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | 0.007▲ | 0.010▲ | 0.020▲ | 0.020▲ |
RSI | 61.993▲ | 67.277▲ | 69.775▲ | 59.020▲ | 58.098▲ |
STOCH | 82.738▲ | 78.335 | 93.247▲ | 63.393 | 44.716 |
WILL %R | 0.000▲ | -6.061▲ | -4.651▲ | -5.882▲ | -32.441 |
CCI | 140.741▲ | 72.819 | 105.517▲ | 168.144▲ | 27.072 |
Thursday, July 25, 2024 01:05 PM
NOVATO, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultrarare genetic ...
|
Monday, July 22, 2024 10:13 AM
BofA Securities raised the price target for the ATRenew Inc ADR (NYSE:RERE) stock to “a Buy”. The rating was released on July 15, 2021, according to finviz.
|
Sunday, July 21, 2024 05:30 AM
The broader market rally has left many investors wondering if there are any growth stocks to buy before a correction. I believe that there absolutely are. Despite the run-up, a number of ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
26/07/24 | 2.40 | 2.565 | 2.3806 | 2.54 | 852,981 |
25/07/24 | 2.38 | 2.44 | 2.33 | 2.38 | 621,445 |
24/07/24 | 2.38 | 2.45 | 2.35 | 2.44 | 931,690 |
23/07/24 | 2.28 | 2.44 | 2.24 | 2.38 | 1,190,417 |
22/07/24 | 2.20 | 2.29 | 2.185 | 2.28 | 682,835 |
19/07/24 | 2.26 | 2.26 | 2.14 | 2.17 | 956,932 |
18/07/24 | 2.32 | 2.32 | 2.22 | 2.235 | 518,560 |
17/07/24 | 2.26 | 2.37 | 2.22 | 2.23 | 743,100 |
16/07/24 | 2.35 | 2.35 | 2.28 | 2.29 | 423,021 |
15/07/24 | 2.36 | 2.36 | 2.25 | 2.26 | 556,661 |
|
|
||||
|
|
||||
|
|